Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.
about
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryHematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatmentGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsHematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Eculizumab in Transplant-Associated Thrombotic Microangiopathy.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.Onco-nephrology: AKI in the cancer patient.Onco-nephrology: current concepts and future perspectives.Acute kidney injury in HCT: an update.Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.Doxycycline for haematopoietic stem cell transplantation-related thrombotic microangiopathy.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy.Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.Successful Treatment of Transplant Associated Thrombotic Microangiopathy (TA-TMA) with Low Dose Defibrotide
P2860
Q26992169-0967175F-0AB2-4D2A-8331-E07D0369D038Q28069228-D601C946-F142-40A9-B785-4A5592961AB7Q30276550-E54E2366-8B7C-4A94-9ACE-BEB1D6CD15EAQ33391308-6A7AFF8D-C0EB-4498-B92B-0429BB168B9CQ33392710-F308BEE5-9D8A-44CE-865C-DA2CE390B440Q33396969-1BF304E5-10E8-4A95-906F-2F25CD5A5D4CQ33407913-2CEEF38F-2DC3-44CA-AE1F-5F6BFF6951B9Q33415603-C85768ED-0846-46D4-B875-51E9DDDC7503Q33417613-9497B85F-59A6-4730-807B-892116523CA3Q33417690-5A58BAFC-7D28-42EE-81C9-DF1E1A1C6EECQ33418635-ECFE4DE3-B6C7-4F45-8E2C-3A2D8D96C4CFQ33424902-203D92DE-01B2-4C37-BBDA-8EE138D5F696Q33425079-C62F5DB9-3BCC-4926-9F97-31212EE7B7FAQ33428744-865624AB-D55F-4D13-84D1-91D3E7E973EAQ34448474-EF82758C-81FB-43E2-A54D-E8D57401F49AQ36294351-0CC9B0C7-E2DD-447F-BCD5-1E3B0A865656Q38382457-637750AC-1D3B-4AA2-A0AE-1B9FD1EDDAF5Q38726036-ACA2645A-F460-497C-907B-FBE1B4A8F7BFQ38806679-A7366D75-D60D-4745-90D0-FDAFCEA2F02CQ40096407-3B4FC9A7-A6A3-4D18-8AE9-CCE6E16F796EQ40333097-8CB7014D-D84E-474D-B58A-858DDBBF93BFQ41992358-00A75913-EEFC-4E3A-978C-D42D064686C6Q47763646-64A158E1-F5CD-4D05-BD43-4170E22459EFQ47912606-03E31993-86BD-4885-920A-F925BEBC145DQ48346280-8CA88FBA-9DF2-4A59-B66D-EF68DEB003A4Q52875784-C6C0B453-C0B9-4832-899C-00890BDFA4C0Q56529806-90418F32-EC92-4BC9-AD6A-04BD7E088B34
P2860
Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Thrombotic microangiopathy in ...... tion: diagnosis and treatment.
@ast
Thrombotic microangiopathy in ...... tion: diagnosis and treatment.
@en
type
label
Thrombotic microangiopathy in ...... tion: diagnosis and treatment.
@ast
Thrombotic microangiopathy in ...... tion: diagnosis and treatment.
@en
prefLabel
Thrombotic microangiopathy in ...... tion: diagnosis and treatment.
@ast
Thrombotic microangiopathy in ...... tion: diagnosis and treatment.
@en
P2093
P2860
P1433
P1476
Thrombotic microangiopathy in ...... tion: diagnosis and treatment.
@en
P2093
Alvin H Schmaier
Cecilia M Choi
Michael R Snell
P2860
P304
P356
10.2165/00003495-200969020-00004
P577
2009-01-01T00:00:00Z
P6179
1009621806